Ross Acquisition Corp II (ROSS) Competitors $11.08 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends ROSS vs. GMRE, ALTI, ORC, VINP, ABL, FPI, CHCT, LAND, PKST, and TINVShould you be buying Ross Acquisition Corp II stock or one of its competitors? The main competitors of Ross Acquisition Corp II include Global Medical REIT (GMRE), AlTi Global (ALTI), Orchid Island Capital (ORC), Vinci Partners Investments (VINP), Abacus Life (ABL), Farmland Partners (FPI), Community Healthcare Trust (CHCT), Gladstone Land (LAND), Peakstone Realty Trust (PKST), and Tiga Acquisition (TINV). These companies are all part of the "trading" industry. Ross Acquisition Corp II vs. Global Medical REIT AlTi Global Orchid Island Capital Vinci Partners Investments Abacus Life Farmland Partners Community Healthcare Trust Gladstone Land Peakstone Realty Trust Tiga Acquisition Global Medical REIT (NYSE:GMRE) and Ross Acquisition Corp II (NYSE:ROSS) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, community ranking, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk. Which has higher earnings & valuation, GMRE or ROSS? Global Medical REIT has higher revenue and earnings than Ross Acquisition Corp II. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Medical REIT$137.70M4.28$20.61MN/AN/ARoss Acquisition Corp IIN/AN/A$14.87MN/AN/A Does the media prefer GMRE or ROSS? In the previous week, Global Medical REIT had 1 more articles in the media than Ross Acquisition Corp II. MarketBeat recorded 1 mentions for Global Medical REIT and 0 mentions for Ross Acquisition Corp II. Global Medical REIT's average media sentiment score of 0.00 equaled Ross Acquisition Corp II'saverage media sentiment score. Company Overall Sentiment Global Medical REIT Neutral Ross Acquisition Corp II Neutral Does the MarketBeat Community believe in GMRE or ROSS? Global Medical REIT received 283 more outperform votes than Ross Acquisition Corp II when rated by MarketBeat users. Likewise, 63.74% of users gave Global Medical REIT an outperform vote while only 0.00% of users gave Ross Acquisition Corp II an outperform vote. CompanyUnderperformOutperformGlobal Medical REITOutperform Votes28363.74% Underperform Votes16136.26% Ross Acquisition Corp IIOutperform VotesNo VotesUnderperform Votes1100.00% Is GMRE or ROSS more profitable? Global Medical REIT has a net margin of 4.18% compared to Ross Acquisition Corp II's net margin of 0.00%. Global Medical REIT's return on equity of 1.09% beat Ross Acquisition Corp II's return on equity.Company Net Margins Return on Equity Return on Assets Global Medical REIT4.18% 1.09% 0.45% Ross Acquisition Corp II N/A N/A N/A Do analysts recommend GMRE or ROSS? Global Medical REIT currently has a consensus target price of $11.25, suggesting a potential upside of 25.28%. Given Global Medical REIT's higher possible upside, equities analysts clearly believe Global Medical REIT is more favorable than Ross Acquisition Corp II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Medical REIT 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Ross Acquisition Corp II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do institutionals and insiders hold more shares of GMRE or ROSS? 57.5% of Global Medical REIT shares are owned by institutional investors. Comparatively, 27.8% of Ross Acquisition Corp II shares are owned by institutional investors. 8.2% of Global Medical REIT shares are owned by company insiders. Comparatively, 76.4% of Ross Acquisition Corp II shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryGlobal Medical REIT beats Ross Acquisition Corp II on 11 of the 12 factors compared between the two stocks. Ad Porter & CompanyNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Ross Acquisition Corp II News Delivered to You Automatically Sign up to receive the latest news and ratings for ROSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ROSS vs. The Competition Export to ExcelMetricRoss Acquisition Corp IIHolding Offices IndustryUnclassified SectorNYSE ExchangeMarket Cap$151.46M$418.35M$111.44M$19.25BDividend YieldN/A8.08%N/A3.54%P/E RatioN/A9.049.1341.13Price / SalesN/A95.727.9514.78Price / CashN/A74.9595.6020.83Price / Book-5.2374.23525.095.38Net Income$14.87M$31.01M$2.17M$985.39M7 Day PerformanceN/A-0.84%-0.65%-0.70%1 Month PerformanceN/A-0.47%-0.23%-0.97%1 Year Performance2.21%11.58%15.41%25.06% Ross Acquisition Corp II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ROSSRoss Acquisition Corp IIN/A$11.08flatN/AN/A$151.46MN/A0.003High Trading VolumeGMREGlobal Medical REIT4.4429 of 5 stars$9.19-0.1%$11.25+22.4%+2.0%$602.75M$137.70M39.9630Upcoming EarningsALTIAlTi Global2.0576 of 5 stars$4.02-0.7%$9.00+123.9%-35.8%$562.12M$250.88M-1.77430Upcoming EarningsShort Interest ↑News CoverageORCOrchid Island Capital4.3806 of 5 stars$7.82+0.1%$9.50+21.5%+16.0%$557.88M$177.57M7.452,018Gap DownVINPVinci Partners Investments4.2613 of 5 stars$10.31+0.1%$14.50+40.6%-0.1%$554.47M$91.03M17.47240Upcoming EarningsNews CoverageABLAbacus Life4.3267 of 5 stars$8.64-4.0%$14.30+65.5%+36.0%$552.31M$95.38M-86.3982Upcoming EarningsFPIFarmland Partners3.1418 of 5 stars$11.01-0.8%$15.00+36.2%+9.5%$530.32M$56.65M33.3625Dividend AnnouncementAnalyst UpgradeNews CoverageCHCTCommunity Healthcare Trust2.293 of 5 stars$17.78+0.3%$20.75+16.7%-33.7%$492.52M$114.71M-889.0037Earnings ReportAnalyst ForecastShort Interest ↑News CoverageLANDGladstone Land2.6583 of 5 stars$13.24-0.5%$16.00+20.8%-4.7%$474.50M$89.54M-73.5570Upcoming EarningsShort Interest ↑News CoveragePKSTPeakstone Realty Trust1.1187 of 5 stars$12.98-1.6%$13.00+0.2%+2.0%$471.25M$239.95M-3.2035Dividend AnnouncementNews CoverageGap UpTINVTiga AcquisitionN/A$13.41+2.1%N/A+127.6%$462.65MN/A0.00N/AHigh Trading Volume Related Companies and Tools Related Companies Global Medical REIT Competitors AlTi Global Competitors Orchid Island Capital Competitors Vinci Partners Investments Competitors Abacus Life Competitors Farmland Partners Competitors Community Healthcare Trust Competitors Gladstone Land Competitors Peakstone Realty Trust Competitors Tiga Acquisition Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ROSS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ross Acquisition Corp II Please log in to your account or sign up in order to add this asset to your watchlist. Share Ross Acquisition Corp II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.